Category In The News
ABC2-funded research in the news and a blog post by Al Musella, of the Musella Foundation, about Novocure's promising Optune trial results.
Accelerate Brain Cancer Cure funded Duke University's early work on the vaccine.
ABC2 CEO Max Wallace chaired the gathering of NCI experts and cancer advocates.
Principal Investigators, based in the state of Florida, are invited to apply. Proposal deadline: December 15, 2014.
Dr. Jim Olson and his scientific team will begin injecting brain cancer patients with the cancer detecting Tumor Paint made from the venom of deathstalker scorpions.
ABC2's Fall Associate Sierra Alef-Defoe explores the pediatric brain cancer research landscape in honor of her friend Sydney and in recognition of National Childhood Cancer Awareness Month.
A TV news interview with 5k founder Greg Schnoor about the upcoming event and his support for ABC2.
NCI Director Harold Varmus, ABC2 CEO Max Wallace and prominent cancer researchers exchanged ideas with leading pediatric cancer advocates.
The panel focused on new funding models for disease research foundations, including for-profit direct investment in early stage biotech/medtech companies.
The 17 member advisory panel will help PBTF evaluate research funding priorities and guide investments.